CD19-targeted chimeric antigen receptor (CAR) T cells in CNS relapsed acute lymphoblastic leukemia (ALL).

被引:0
|
作者
Newman, Haley
Leahy, Allison Emily Barz
Li, Yimei
Liu, Hongyan
Myers, Regina M.
DiNofia, Amanda M.
Dolan, Joseph Gregory
Callahan, Colleen
Devine, Kaitlin J.
Wray, Lisa
June, Carl H.
Grupp, Stephan A.
Rheingold, Susan R.
Maude, Shannon L.
机构
[1] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Canc Immunotherapy Program, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA
[4] Childrens Hosp Philadelphia, Perelman Sch Med, Philadelphia, PA 19104 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
10511
引用
收藏
页数:2
相关论文
共 50 条
  • [1] The effect of pembrolizumab in combination with CD19-targeted chimeric antigen receptor (CAR) T cells in relapsed acute lymphoblastic leukemia (ALL)
    Maude, Shannon L.
    Hucks, George E.
    Self, Alix Eden
    Talekar, Mala Kiran
    Teachey, David T.
    Baniewicz, Diane
    Callahan, Colleen
    Gonzalez, Vanessa
    Nazimuddin, Farzana
    Gupta, Minna
    Frey, Noelle V.
    Porter, David L.
    Levine, Bruce L.
    Melenhorst, Jan J.
    Lacey, Simon F.
    June, Carl H.
    Grupp, Stephan A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Humanized CD19-targeted chimeric antigen receptor T (CAR-T) cells for relapsed/refractory pediatric acute lymphoblastic leukemia
    Wang, Shiyuan
    Wang, Xue
    Ye, Chunying
    Cheng, Hai
    Shi, Ming
    Chen, Wei
    Qi, Kunming
    Wang, Gang
    Wu, Qingyun
    Zeng, Lingyu
    Li, Zhenyu
    Jing, Guangjun
    Zheng, Junnian
    Xu, Kailin
    Cao, Jiang
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (05) : E162 - E165
  • [3] Efficacy of humanized CD19-targeted chimeric antigen receptor (CAR)-modified T cells in children with relapsed ALL
    Maude, Shannon L.
    Barrett, David Maxwell
    Rheingold, Susan R.
    Aplenc, Richard
    Teachey, David T.
    Callahan, Colleen
    Shaw, Pamela A.
    Brogdon, Jennifer
    Young, Regina
    Scholler, John
    Marcucci, Katherine
    Kulikovskaya, Irina
    Nazimuddin, Farzana
    Zheng, Zhaohui
    Levine, Bruce
    Porter, David L.
    Lacey, Simon F.
    Melenhorst, Jan Joseph
    June, Carl H.
    Grupp, Stephan A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] Efficacy of Humanized CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells in Children and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
    Maude, Shannon L.
    Barrett, David M.
    Rheingold, Susan R.
    Aplenc, Richard
    Teachey, David T.
    Callahan, Colleen
    Baniewicz, Diane
    White, Claire
    Talekar, Mala K.
    Shaw, Pamela A.
    Brogdon, Jennifer L.
    Young, Regina M.
    Scholler, John
    Marcucci, Katherine T.
    Levine, Bruce L.
    Frey, Noelle
    Porter, David L.
    Lacey, Simon F.
    Melenhorst, J. Joseph
    June, Carl H.
    Grupp, Stephan A.
    [J]. BLOOD, 2016, 128 (22)
  • [5] Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia
    Cao, Jiang
    Wang, Gang
    Cheng, Hai
    Wei, Chen
    Qi, Kunming
    Sang, Wei
    Li Zhenyu
    Shi, Ming
    Li, Huizhong
    Qiao, Jianlin
    Pan, Bin
    Zhao, Jing
    Wu, Qingyun
    Zeng, Lingyu
    Niu, Mingshan
    Jing, Guangjun
    Zheng, Junnian
    Xu, Kailin
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (07) : 851 - 858
  • [6] CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
    Maude, Shannon L.
    Teachey, David T.
    Porter, David L.
    Grupp, Stephan A.
    [J]. BLOOD, 2015, 125 (26) : 4017 - 4023
  • [7] Efficacy of Retreatment with Humanized CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells in Children with Relapsed ALL
    Maude, S.
    Barrett, D.
    Rheingold, S.
    Aplenc, R.
    Teachey, D.
    Callahan, C.
    Shaw, P.
    Brogdon, J.
    Young, R.
    Scholler, J.
    Marcucci, K.
    Levine, B.
    Porter, D.
    Lacey, S.
    Melenhorst, J.
    June, C.
    Grupp, S.
    [J]. PEDIATRIC BLOOD & CANCER, 2016, 63 : S37 - S37
  • [8] Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia
    Myers, Regina M.
    Li, Yimei
    Leahy, Allison Barz
    Barrett, David M.
    Teachey, David T.
    Callahan, Colleen
    Fasano, Christina C.
    Rheingold, Susan R.
    DiNofia, Amanda
    Wray, Lisa
    Aplenc, Richard
    Baniewicz, Diane
    Liu, Hongyan
    Shaw, Pamela A.
    Pequignot, Edward
    Getz, Kelly D.
    Brogdon, Jennifer L.
    Fesnak, Andrew D.
    Siegel, Donald L.
    Davis, Megan M.
    Bartoszek, Chelsie
    Lacey, Simon F.
    Hexner, Elizabeth O.
    Chew, Anne
    Wertheim, Gerald B.
    Levine, Bruce L.
    June, Carl H.
    Grupp, Stephan A.
    Maude, Shannon L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (27) : 3044 - +
  • [9] Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells
    Kline, Kathryn
    Luetkens, Tim
    Koka, Rima
    Kallen, Michael E.
    Chen, Wengen
    Ahmad, Haroon
    Omili, Destiny
    Iraguha, Thierry
    Gebru, Etse
    Fan, Xiaoxuan
    Miller, Alexis
    Dishanthan, Nishanthini
    Baker, Jillian M.
    Dietze, Kenneth A.
    Hankey, Kim G.
    Yared, Jean A.
    Hardy, Nancy M.
    Rapoport, Aaron P.
    Dahiya, Saurabh
    Atanackovic, Djordje
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (03)
  • [10] Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells
    Kathryn Kline
    Tim Luetkens
    Rima Koka
    Michael E. Kallen
    Wengen Chen
    Haroon Ahmad
    Destiny Omili
    Thierry Iraguha
    Etse Gebru
    Xiaoxuan Fan
    Alexis Miller
    Nishanthini Dishanthan
    Jillian M. Baker
    Kenneth A. Dietze
    Kim G. Hankey
    Jean A. Yared
    Nancy M. Hardy
    Aaron P. Rapoport
    Saurabh Dahiya
    Djordje Atanackovic
    [J]. Cancer Immunology, Immunotherapy, 73